{"id":1350690,"title":"DSEN Abstract: Safety, Effectiveness and Cost-effectiveness of Direct Oral Anti-coagulants in Patients with Atrial Fibrillation - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-19","captureTimestamp":"2026-02-19T19:58:10.624000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/51391.html?wbdisable=true","snippet":"DSEN Abstract Safety, Effectiveness and Cost-effectiveness of Direct Oral Anti-coagulants in Patients with Atrial Fibrillation This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following investigators: George Wells, Doug Coyle,…","rawSnapshotUrl":"/api/snapshots/raw/1350690","browseUrl":"https://replay.healtharchive.ca/job-8/20260219195810/https://cihr-irsc.gc.ca/e/51391.html?wbdisable=true#ha_snapshot=1350690","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}